BD BBL™ Trypticase™ Soy Agar W/5% SB(TSA II) /Mac II Agar 221290Recalls & reported problems
Becton, Dickinson And Company · Plate Tsa II SB//Mac II 20 Ea · Class 1
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10382902212901), received between Mar 2, 2021 and Aug 11, 2021 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Contamination” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Contamination2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 11, 2021Contamination; Contamination
IT WAS REPORTED THAT THE MEDIA WAS CONTAMINATED WITH BD BBL¿ TRYPTICASE¿ SOY AGAR WITH 5% SHEEP BLOOD (TSA II) // MACCONKEY II AGAR. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER REPORTING BACTERIAL CONTAMINATION IN MEDIA PRODUCT 221290 LOT 1099128 - PLATE TSA II SB/ MAC II.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12309229 ↗MalfunctionMar 2, 2021Contamination; Contamination
IT WAS REPORTED THAT WHILE USING BD BBL¿ TRYPTICASE¿ SOY AGAR WITH 5% SHEEP BLOOD (TSA II) // MACCONKEY II AGAR CONTAMINATION WAS OBSERVED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11401384 ↗
Other CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL devices
- BD BBL™ Enriched Thioglycollate Medium 221788Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL160 reports
- BD BBL™ Trypticase™ Soy Agar with 5% Sheep Blood and MacConkey II Agar I Plate™ 221291Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL106 reports
- BD BBL™ Trypticase™ Soy Agar with 5% Sheep Blood (TSA II) 221261Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL1 recall51 reports
- BD BBL™ CDC Anaerobe 5% Sheep Blood Agar 221734Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL63 reports
- BD BBL™ Fluid Thioglycollate Medium 221196Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL1 recall4 reports
- BD BBL™ Trypticase™ Soy Broth 221716Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL31 reports
- BD BBL™ Trypticase™ Soy Broth 297354Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL27 reports
- BD BBL™ Trypticase™ Soy Agar (Soybean-Casein Digest Agar) 221283Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL19 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.